{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:08:12Z","timestamp":1789826892155,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":538,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA155769"],"award-info":[{"award-number":["R01CA155769"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA236500"],"award-info":[{"award-number":["R01CA236500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA254271"],"award-info":[{"award-number":["R01CA254271"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19CA264512"],"award-info":[{"award-number":["U19CA264512"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA209978"],"award-info":[{"award-number":["U54CA209978"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s13311-022-01207-w","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T10:13:09Z","timestamp":1646043189000},"page":"635-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery"],"prefix":"10.1016","volume":"19","author":[{"given":"Shunan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyuzhi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei Holly","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritro","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric F.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Bild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Badie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-022-01207-w_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1007\/s13311-022-01207-w_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat Med"},{"key":"10.1007\/s13311-022-01207-w_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41591-018-0339-5","article-title":"Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma","volume":"25","author":"Schalper","year":"2019","journal-title":"Nat Med"},{"key":"10.1007\/s13311-022-01207-w_bib4","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/2159-8290.CD-16-0577","article-title":"Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease","volume":"6","author":"Liu","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1007\/s13311-022-01207-w_bib5","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.2741\/2968","article-title":"Surgical brain injury: prevention is better than cure","volume":"13","author":"Jadhav","year":"2008","journal-title":"Front Biosci"},{"key":"10.1007\/s13311-022-01207-w_bib6","first-page":"1048","volume":"27","author":"Nayak","year":"2021","journal-title":"Randomized phase II and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for patients with recurrent glioblastoma"},{"key":"10.1007\/s13311-022-01207-w_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1078-0432.CCR-20-2291","article-title":"Concurrent dexamethasone limits the clinical benefit of immune checkpoint blockade in glioblastoma","volume":"27","author":"Iorgulescu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1007\/s13311-022-01207-w_bib8","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1089\/neu.2018.6320","article-title":"Monitoring of protein biomarkers of inflammation in human traumatic brain injury using microdialysis and proximity extension assay technology in neurointensive care","volume":"36","author":"Dyhrfort","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1007\/s13311-022-01207-w_bib9","doi-asserted-by":"crossref","unstructured":"Sorci G, Bianchi R, Riuzzi F, Tubaro C, Arcuri C, Giambanco I, et al. S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond. Cardiovasc Psychiatry Neurol. 2010;2010.","DOI":"10.1155\/2010\/656481"},{"key":"10.1007\/s13311-022-01207-w_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.jcbfm.9600582","article-title":"Early release of HMGB-1 from neurons after the onset of brain ischemia","volume":"28","author":"Qiu","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-022-01207-w_bib11","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","article-title":"Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats","volume":"42","author":"Zhang","year":"2011","journal-title":"Stroke"},{"key":"10.1007\/s13311-022-01207-w_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2014.05.007","article-title":"Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1\u2013RAGE interaction","volume":"85","author":"Okuma","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-022-01207-w_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbamcr.2012.10.021","article-title":"RAGE in tissue homeostasis, repair and regeneration","volume":"1833","author":"Sorci","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1007\/s13311-022-01207-w_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1189\/jlb.0409230","article-title":"RAGE: therapeutic target and biomarker of the inflammatory response\u2013the evidence mounts","volume":"86","author":"Ramasamy","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1007\/s13311-022-01207-w_bib15","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1158\/0008-5472.CAN-14-1240","article-title":"RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res"},{"key":"10.1007\/s13311-022-01207-w_bib16","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1158\/1078-0432.CCR-19-2520","article-title":"Local and systemic immune dysregulation alters glioma growth in hyperglycemic mice","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1007\/s13311-022-01207-w_bib17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/bioinformatics\/btw817","article-title":"Planning bioinformatics workflows using an expert system","volume":"33","author":"Chen","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1007\/s13311-022-01207-w_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1007\/s13311-022-01207-w_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1007\/s13311-022-01207-w_bib20","doi-asserted-by":"crossref","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, 3rd, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888\u2013902 e21.","DOI":"10.1016\/j.cell.2019.05.031"},{"key":"10.1007\/s13311-022-01207-w_bib21","doi-asserted-by":"crossref","unstructured":"Wolock SL, Lopez R, Klein AM. Scrublet: Computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 2019;8:281\u201391 e9.","DOI":"10.1016\/j.cels.2018.11.005"},{"key":"10.1007\/s13311-022-01207-w_bib22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1471-2164-14-632","article-title":"An expression atlas of human primary cells: inference of gene function from coexpression networks","volume":"14","author":"Mabbott","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1007\/s13311-022-01207-w_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1007\/s13311-022-01207-w_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/glia.21118","article-title":"S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway","volume":"59","author":"Zhang","year":"2011","journal-title":"Glia"},{"key":"10.1007\/s13311-022-01207-w_bib25","doi-asserted-by":"crossref","unstructured":"Zhang I, Alizadeh D, Liang J, Zhang L, Gao H, Song Y, et al. Characterization of arginase expression in glioma-associated microglia and macrophages. PLoS One. 2016;11:e0165118.","DOI":"10.1371\/journal.pone.0165118"},{"key":"10.1007\/s13311-022-01207-w_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1471-2105-6-225","article-title":"Pathway level analysis of gene expression using singular value decomposition","volume":"6","author":"Tomfohr","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"10.1007\/s13311-022-01207-w_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neulet.2019.02.012","article-title":"Proinflammatory and amyloidogenic S100A9 induced by traumatic brain injury in mouse model","volume":"699","author":"Wang","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-022-01207-w_bib28","doi-asserted-by":"crossref","first-page":"12836","DOI":"10.1038\/s41598-018-31141-x","article-title":"S100A9-driven amyloid-neuroinflammatory cascade in traumatic brain injury as a precursor state for Alzheimer's disease","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-022-01207-w_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-022-01207-w_bib30","first-page":"223","article-title":"Mechanism of action and clinical activity of tasquinimod in castrate-resistant prostate cancer","volume":"7","author":"Gupta","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1007\/s13311-022-01207-w_bib31","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid \u03b2\u2013mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1007\/s13311-022-01207-w_bib32","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/STROKEAHA.114.008336","article-title":"Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage","volume":"46","author":"Yang","year":"2015","journal-title":"Stroke"},{"key":"10.1007\/s13311-022-01207-w_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/acschemneuro.0c00530","article-title":"FPS-ZM1 Alleviates neuroinflammation in focal cerebral ischemia rats via blocking ligand\/RAGE\/DIAPH1 pathway","volume":"12","author":"Shen","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1007\/s13311-022-01207-w_bib34","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rk P, Bj\u00f6rk A, Vogl T, Stenstr\u00f6m M, Liberg D, Olsson A, et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biology. 2009;7:e1000097.","DOI":"10.1371\/journal.pbio.1000097"},{"key":"10.1007\/s13311-022-01207-w_bib35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3171\/jns.2000.93.4.0634","article-title":"Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study","volume":"93","author":"Badie","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-022-01207-w_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymthe.2017.10.002","article-title":"Optimization of IL13Ralpha2-targeted chimeric antigen receptor T cells for improved anti-tumor efficacy against glioblastoma","volume":"26","author":"Brown","year":"2018","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-022-01207-w_bib37","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-022-01207-w_bib38","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-15-0428","article-title":"Bioactivity and safety of IL13Ralpha2-redirected chimeric antigen receptor CD8+ T cells in patients with recurrent glioblastoma","volume":"21","author":"Brown","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1007\/s13311-022-01207-w_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-014-1415-4","article-title":"A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent","volume":"118","author":"Portnow","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1007\/s13311-022-01207-w_bib40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/TA.0b013e31823c54a6","article-title":"Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury","volume":"72","author":"Gao","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1007\/s13311-022-01207-w_bib41","doi-asserted-by":"crossref","first-page":"46243","DOI":"10.1038\/srep46243","article-title":"Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-022-01207-w_bib42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s12035-016-9703-y","article-title":"Inhibition of the receptor for advanced glycation end-products (RAGE) attenuates neuroinflammation while sensitizing cortical neurons towards death in experimental subarachnoid hemorrhage","volume":"54","author":"Li","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-022-01207-w_bib43","doi-asserted-by":"crossref","unstructured":"Qiu X, Ping S, Kyle M, Longo J, Chin L, Zhao LR. S100 Calcium-binding protein A9 knockout contributes to neuroprotection and functional improvement after traumatic brain injury. J Neurotrauma. 2019.","DOI":"10.1089\/neu.2018.6170"},{"key":"10.1007\/s13311-022-01207-w_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-013-2321-8","article-title":"Mechanisms of action of tasquinimod on the tumour microenvironment","volume":"73","author":"Raymond","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1007\/s13311-022-01207-w_bib45","doi-asserted-by":"crossref","unstructured":"Kallberg E, Vogl T, Liberg D, Olsson A, Bjork P, Wikstrom P, et al. S100A9 interaction with TLR4 promotes tumor growth. PLoS One. 2012;7:e34207.","DOI":"10.1371\/journal.pone.0034207"},{"key":"10.1007\/s13311-022-01207-w_bib46","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3389\/fimmu.2019.02243","article-title":"S100A9 regulates MDSCs-mediated immune suppression via the RAGE and TLR4 signaling pathways in colorectal carcinoma","volume":"10","author":"Huang","year":"2019","journal-title":"Front Immunol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01207-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:35:16Z","timestamp":1761806116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1878747923000776"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01207-w","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01207-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}